... is an antirheumatic agent. Iversen M, Munck J, Schourup K (1953). "On the toxicity of 3-hydroxy-2- ... Antirheumatic products, Quinolinols, Alpha hydroxy acids, All stub articles, Musculoskeletal system drug stubs). ...
It is an antirheumatic agent in veterinary medicine. It has attracted interest as an anticancer agent. Aminopropionitrile is ...
... is an antirheumatic agent developed from tiopronin. Activity is mediated by the two thiol groups that the molecule ... Antirheumatic products, Carboxylic acids, Propionamides, Thiols, All stub articles, Musculoskeletal system drug stubs). ...
Some cucurbitacins can be made anti-rheumatic agent. "Cucurbitaceae Cayaponia tayuya". International Plant Names Index. ...
... is a gold salt used as an antirheumatic agent. Perrier P, Raffoux C, Thomas P, Tamisier JN, Busson M, Gaucher A, ... levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up ... Antirheumatic products, Metal-containing drugs, All stub articles, Musculoskeletal system drug stubs). ...
The main uses of mepacrine are as an antiprotozoal, antirheumatic, and an intrapleural sclerosing agent. Antiprotozoal use ... Antiprotozoal agents, Antimalarial agents, Sterilization (medicine), Experimental methods of birth control, Acridines, ... Agents Chemother. 55 (5): 1827-1830. doi:10.1128/aac.01296-10. PMC 3088196. PMID 21383088. Canete R, Escobedo AA, Gonzalez ME, ... As an intrapleural sclerosing agent, it is used as pneumothorax prophylaxis in patients at high risk of recurrence, e.g., ...
... is a gold salt classified by the World Health Organization as an antirheumatic agent. It has the brand name Ridaura. ... Antirheumatic products, Acetate esters, Metal-containing drugs, Gold-sulfur compounds, Disease-modifying antirheumatic drugs). ... the protozoan agent of human amebiasis. Assays of thioredoxin reductase and transcriptional profiling suggest that the effect ... International Journal of Antimicrobial Agents. 58 (5): 106425. doi:10.1016/j.ijantimicag.2021.106425. PMID 34419578. S2CID ...
... a toxic blistering agent once used as an exfoliating agent, anti-rheumatic drug and an aphrodisiac. The substance has also ... Cantharidin, the active agent, is a terpenoid, and is produced by some other insects, such as Epicauta immaculata. Cantharidin ... The beetle secretes the agent orally, and exudes it from its joints as a milky fluid. The potency of the insect as a blistering ... Note: the active agent appears variously as cantharidin,: 41 and "cantharadin": 43, 45ff or "canthariadin": 238 (sic). Aggrawal ...
Antimalarial agents, Antirheumatic products, Articles containing video clips, Chloroarenes, HERG blocker, Primary alcohols, ... Both agents also inhibit CYP2D6 activity and may interact with other medications that depend on this enzyme. Antimalarials are ... It enhances hypoglycemic effects of insulin and oral hypoglycemic agents. Dose altering is recommended to prevent profound ... "Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents". ...
Antirheumatic products, Chelating agents, Enantiopure drugs, Human drug metabolites, Nephrotoxins, Non-proteinogenic amino ... It is used as a chelating agent: In Wilson's disease, a rare genetic disorder of copper metabolism, penicillamine treatment ... Penicillamine can be used as a disease-modifying antirheumatic drug (DMARD) to treat severe active rheumatoid arthritis in ... although it is rarely used today due to availability of TNF inhibitors and other agents, such as tocilizumab and tofacitinib. ...
"Studies on antirheumatic agents: 3-benzoylpropionic acid derivatives", Chem. Pharm. Bull., vol. 36, no. 6, pp. 2050-2060, doi: ...
The term is often used in contrast to nonsteroidal anti-inflammatory drugs (which refers to agents that treat the inflammation ... "Disease modifying antirheumatic drugs (DMARDs)". "antirheumatic" at Dorland's Medical Dictionary Buer, Jonas Kure (2015). "A ... Disease-modifying antirheumatic drugs (DMARDs) comprise a category of otherwise unrelated disease-modifying drugs defined by ... Nandi P, Kingsley GH, Scott DL (May 2008). "Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid ...
975 Poisoning by agents primarily acting on the smooth and skeletal muscles and respiratory system 976 Poisoning by agents ... and antirheumatics 966 Poisoning by anticonvulsants and anti-Parkinsonism drugs 967 Poisoning by sedatives and hypnotics 968 ... the autonomic nervous system 972 Poisoning by agents primarily affecting the cardiovascular system 973 Poisoning by agents ... 962 Poisoning by hormones and synthetic substitutes 963 Poisoning by primarily systemic agents 964 Poisoning by agents ...
Prognosis of acquired immune deficiencies depends on avoiding or treating the causative agent or condition (like AIDS). ... disease-modifying antirheumatic drugs, immunosuppressive drugs after organ transplants, glucocorticoids) and environmental ... can result from various immunosuppressive agents, for example, malnutrition, aging, particular medications (e.g., chemotherapy ...
Anti-inflammatory agents, Hepatotoxins, Neuroprotective agents, NMDA receptor antagonists, PARP inhibitors, Pfizer brands, ... Tetracycline antibiotics, Triketones, Disease-modifying antirheumatic drugs, Wikipedia medicine articles ready to translate). ... In ongoing research and trial, minocycline demonstrated efficacy and seems a promising neuroprotective agent in acute stroke ... Antimicrobial Agents and Chemotherapy. 39 (1): 276-277. doi:10.1128/AAC.39.1.276. PMC 162527. PMID 7695324. Beal MF, Ferrante ...
... adverse effects in therapeutic use E933 Primarily systemic agents causing adverse effects in therapeutic use E934 Agents ... at Unspecified place E849.0 Place of occurrence at home E850 Accidental poisoning by analgesics antipyretics and antirheumatics ... use E942 Agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use E943 Agents primarily ... in therapeutic use E944 Water mineral and uric acid metabolism drugs causing adverse effects in therapeutic use E945 Agents ...
Anti-inflammatory agents, Azetidines, Breakthrough therapy, COVID-19 drug development, Non-receptor tyrosine kinase inhibitors ... Pyrazoles, Pyrrolopyrimidines, Sulfonamides, Disease-modifying antirheumatic drugs, Nitriles). ...
Its advantage over that drug in the treatment of ulcerative colitis is believed to be the delivery of the active agent past the ... It is in the category of disease-modifying antirheumatic drugs (DMARDs) family of medications. It is unclear exactly how it ...
It went out of interest until 1924 when it was noted as a chemotherapeutic agent for tuberculosis by Holger Møllgaard in ... Like several other gold compounds, this species is used as an antirheumatic. The first placebo-controlled trial was probably ... Shaw III CF (September 1999). "Gold-based therapeutic agents". Chemical Reviews. 99 (9): 2589-600. doi:10.1021/cr980431o. PMID ... Antirheumatic products, Metal-containing drugs, Gold-sulfur compounds, Aurates, All stub articles, Musculoskeletal system drug ...
Other agents which have been shown to reverse chloroquine resistance in malaria are chlorpheniramine, gefitinib, imatinib, ... Disease-modifying antirheumatic drugs). ... in pre-clinical models as a potential agent against chikungunya ... July 2012). "Sontochin as a guide to the development of drugs against chloroquine-resistant malaria". Antimicrobial Agents and ... Chloroquine is also a lysosomotropic agent, meaning it accumulates preferentially in the lysosomes of cells in the body.[ ...
Where this condition has been correctly diagnosed, various anti-rheumatic drugs as well as colchicine may be trialled to find ... achieved using intra-articular agents (chemical or radioactive) can provide good results, with efficacy reported for at least 1 ... Low-dose colchicine (and some other 'anti-rheumatic' therapies e.g. hydroxychloroquine) have been used with some success. (Use ...
The biologic agent rituximab (anti-B cell therapy) is now licensed for use in refractory rheumatoid arthritis.Physiotherapy is ... disease-modifying antirheumatic drugs), monoclonal antibodies, such as infliximab and adalimumab, the TNF inhibitor etanercept ...
It is considered a promising agent as it inhibits JAK1 selectively, similar to already marketed upadacitinib.[medical citation ... modifying anti‑rheumatic drugs (DMARDs). Filgotinib may be used as monotherapy or in combination with methotrexate (MTX). ... Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment (FINCH 2)" at ... on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic ...
In 1959 it became the eighth cytotoxic anticancer agent to be approved by the FDA. The abbreviation CP is common, although ... it remains an important treatment for life-threatening autoimmune diseases where disease-modifying antirheumatic drugs (DMARDs ... The main use of cyclophosphamide is with other chemotherapy agents in the treatment of lymphomas, some forms of brain cancer, ... Like other alkylating agents, cyclophosphamide is teratogenic and contraindicated in pregnant women (pregnancy category D) ...
... antirheumatic agents MeSH D27.505.954.329.030 - anti-inflammatory agents, non-steroidal MeSH D27.505.954.329.337 - gout ... antiviral agents MeSH D27.505.954.122.388.077 - anti-retroviral agents MeSH D27.505.954.122.388.077.088 - anti-hiv agents MeSH ... tocolytic agents MeSH D27.505.954.016 - anti-allergic agents MeSH D27.505.954.122 - anti-infective agents MeSH D27.505.954.122. ... tranquilizing agents MeSH D27.505.696.277.950.015 - anti-anxiety agents MeSH D27.505.696.277.950.025 - antimanic agents MeSH ...
Biological agents should generally be used only if methotrexate and other conventional agents are not effective after a trial ... Disease-modifying antirheumatic drugs (DMARDs), such as hydroxychloroquine and methotrexate, may be used to try to slow the ... The most commonly used agent is methotrexate with other frequently used agents including sulfasalazine and leflunomide. ... No infectious agent has been consistently linked with RA and there is no evidence of disease clustering to indicate its ...
He carried out research into the effect of salicin, an extract from willow bark and a known anti-rheumatic treatment. This work ... Stewart, William K.; Fleming, L. W. (1 October 1987). "Perthshire Pioneer of Anti-Inflammatory Agents". Scottish Medical ...
June 1995). "A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis ... "Rationally designed multitarget agents against inflammation and pain". Current Medicinal Chemistry. 20 (13): 1783-99. doi: ...
... as its conjugate base is a chelating agent, with an affinity for iron(III). Salicylic acid slowly degrades to ... Salicylate's antirheumatic (nonsteroidal anti-inflammatory) actions are a result of its analgesic and anti-inflammatory ... Aminosalicylic acid is used to induce remission in ulcerative colitis, and has been used as an antitubercular agent often ... Chelating agents, Monohydroxybenzoic acids, Nonsteroidal anti-inflammatory drugs, Plant hormones, World Health Organization ...
People who have previously been treated with an alkylating agent may have an excessive risk of cancers if treated with ... Being a disease-modifying antirheumatic drug (DMARD), azathioprine has been used for the management of the signs and symptoms ... It is also an important therapy and steroid-sparing agent for inflammatory bowel disease (such as Crohn's disease and ... agent. Azathioprine is also used to maintain remission in people who have granulomatosis with polyangiitis. It can be very ...